Synthesis of a water soluble boron neutron capture therapy agent: 1-amino-3-[2-(7-{3-[2-(2-hydroxymethyl-ethoxy)-1-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)ethoxy]propyl}-1,7-di-carba-closo-dodecaboran-1-yl)ethyl]cyclobutanecarboxylic acid
Bc. Das et al., Synthesis of a water soluble boron neutron capture therapy agent: 1-amino-3-[2-(7-{3-[2-(2-hydroxymethyl-ethoxy)-1-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)ethoxy]propyl}-1,7-di-carba-closo-dodecaboran-1-yl)ethyl]cyclobutanecarboxylic acid, J ORGMET CH, 614, 2000, pp. 255-261
A water soluble boronated amino acid containing a cascade polyol, 1-amino-3
-[2-(7-{3-[2-(2-hydroxymethyl-ethoxy)-1-(2-hydroxy-1-hydroxymethyl-ethoxyme
thyl)ethoxy]propyl}-1,7-di-carba-closo-dodecarboran-1-yl)ethyl]cyclobutanec
arboxylic acid,has been developed. The key step in the synthesis is the alk
ylation of 3-[2-(1,7-dicarba-closo-docfecarboran-1-yl)ethyl]cyclobutanone h
emithioketal with toluene-4-sulfonic acid 3-[2-(2-benzyloxy-1-benzyloxymeth
yl-ethoxy)-1-(2-benzyloxy-1-benzyloxymethyl-ethoxymethyl)ethoxy]propyl este
r which gave the required precursor ketone which was then converted to the
title amino acid via a Bucherer-Strecker synthesis followed by hydrogenolys
is to remove the benzyl protecting groups. (C) 2000 Elsevier Science B.V. A
ll rights reserved.